BioSpace News Archive

Improvements to large diameter devices include accessiblity through smaller sheaths while providing enhanced visualization under fluoroscopy

Cloud DX, a leading provider of virtual care and remote patient monitoring solutions, today announced the U.S. launch of its updated Connected Health Kit, alongside a new quick-start program enabling health providers and care teams to quickly and cost-effectively expand remote patient monitoring during the COVID-19 pandemic.

Naviswiss US announced the first successful U.S. surgery with its hand-held hip navigation system in New York City, NY. Dr. Alejandro Della Valle performed the procedure using the imageless system and accurately placing implants during a total hip replacement.

Genosity, Inc., an innovative biotechnology company that provides comprehensive software and technical solutions to enable precision medicine announced today that it has entered into a strategic collaboration with Personal Genome Diagnostics Inc. (PGDx), one of the leading companies in cancer genomics, that recently received market clearance from the U.S. Food and Drug Administration (FDA) for PGDx elio™ tissue complete

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug candidate, in endometrial cancer.

Newswire’s Earned Media Advantage Guided Tour Market Builder presents a major opportunity for medical manufacturers, medical tech firms, and healthcare leaders heading into the winter season.

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, today announced the appointment of Sam Osman to its Board of Directors.

Visuals will accompany distribution of company’s GenViro! Swift Kits globally and also be posted on the website in English, and with sub-titles in German, Russian, Spanish and French

RNA-based therapeutics and vaccines refer to prophylactic medications, which are generally used in the treatment of diverse critical diseases including diabetes, cancer, tuberculosis, and several cardiovascular conditions.

Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study to assess the safety and efficacy of XZ.700 in patients with mild to moderate atopic dermatitis.